Brought to you by 
3F Therapeutics brings in $14.2mm with first tranche
19 Oct 2005
Executive Summary
3F Therapeutics (cardiac and circulatory devices) has brought in $14.2mm with the first tranche of its Series D financing. New investor Boston Scientific Corp. led the private placement and was joined by returning investors Domain Associates, Cardiac Concepts, and 3i Bioscience. The company anticipates raising another $10mm with the second tranche. Stifel, Nicolaus & Co. assisted with the transaction.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
3F Therapeutics brings in $14.2mm with first tranche
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice